These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
202 related items for PubMed ID: 8985100
41. Expression of matrix metalloproteinases (MMP-2 and -9) and tissue inhibitors of metalloproteinases (TIMP-1 and -2) in acute myelogenous leukaemia blasts: comparison with normal bone marrow cells. Janowska-Wieczorek A, Marquez LA, Matsuzaki A, Hashmi HR, Larratt LM, Boshkov LM, Turner AR, Zhang MC, Edwards DR, Kossakowska AE. Br J Haematol; 1999 May; 105(2):402-11. PubMed ID: 10233411 [Abstract] [Full Text] [Related]
42. [Matrix metalloproteinase-2 concentrations in squamous cell carcinoma of the head and neck and its clinical significance]. Kawata R, Shinomiya T, Yasuda N, Takenaka H, Murakami Y. Nihon Jibiinkoka Gakkai Kaiho; 1996 Feb; 99(2):299-305. PubMed ID: 8851335 [Abstract] [Full Text] [Related]
43. Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumor cell lines. Afzal S, Lalani el-N, Foulkes WD, Boyce B, Tickle S, Cardillo MR, Baker T, Pignatelli M, Stamp GW. Lab Invest; 1996 Feb; 74(2):406-21. PubMed ID: 8780160 [Abstract] [Full Text] [Related]
44. Mechanism for bone invasion of oral cancer cells mediated by interleukin-6 in vitro and in vivo. Okamoto M, Hiura K, Ohe G, Ohba Y, Terai K, Oshikawa T, Furuichi S, Nishikawa H, Moriyama K, Yoshida H, Sato M. Cancer; 2000 Nov 01; 89(9):1966-75. PubMed ID: 11064354 [Abstract] [Full Text] [Related]
45. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. Mackay AR, Ballin M, Pelina MD, Farina AR, Nason AM, Hartzler JL, Thorgeirsson UP. Invasion Metastasis; 1992 Nov 01; 12(3-4):168-84. PubMed ID: 1284126 [Abstract] [Full Text] [Related]
46. 72-kD (MMP-2) and 92-kD (MMP-9) type IV collagenase production and activity in different histologic types of lung cancer cells. González-Avila G, Iturria C, Vadillo F, Terán L, Selman M, Pérez-Tamayo R. Pathobiology; 1998 Nov 01; 66(1):5-16. PubMed ID: 9577961 [Abstract] [Full Text] [Related]
47. Role of the matrix metalloproteinase and tissue inhibitors of metalloproteinase families in noninvasive and invasive tumors transplanted in mice with severe combined immunodeficiency. Furukawa A, Tsuji M, Nishitani M, Kanda K, Inoue Y, Kanayama H, Kagawa S. Urology; 1998 May 01; 51(5):849-53. PubMed ID: 9610608 [Abstract] [Full Text] [Related]
48. Role of tissue inhibitor of metalloproteinases-2 (TIMP-2) in regulation of pro-gelatinase A activation catalyzed by membrane-type matrix metalloproteinase-1 (MT1-MMP) in human cancer cells. Shofuda K, Moriyama K, Nishihashi A, Higashi S, Mizushima H, Yasumitsu H, Miki K, Sato H, Seiki M, Miyazaki K. J Biochem; 1998 Aug 01; 124(2):462-70. PubMed ID: 9685743 [Abstract] [Full Text] [Related]
49. Activation of tumor cell matrix metalloproteinase-2 by neutrophil proteinases requires expression of membrane-type 1 matrix metalloproteinase. Schwartz JD, Shamamian P, Monea S, Whiting D, Marcus SG, Galloway AC, Mignatti P. Surgery; 1998 Aug 01; 124(2):232-8. PubMed ID: 9706143 [Abstract] [Full Text] [Related]
50. Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer. Impola U, Uitto VJ, Hietanen J, Hakkinen L, Zhang L, Larjava H, Isaka K, Saarialho-Kere U. J Pathol; 2004 Jan 01; 202(1):14-22. PubMed ID: 14694517 [Abstract] [Full Text] [Related]
51. Activation of MMP-2 and MMP-9 in patients with oral squamous cell carcinoma. Patel BP, Shah PM, Rawal UM, Desai AA, Shah SV, Rawal RM, Patel PS. J Surg Oncol; 2005 May 01; 90(2):81-8. PubMed ID: 15844188 [Abstract] [Full Text] [Related]
52. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion. Di Nezza LA, Misajon A, Zhang J, Jobling T, Quinn MA, Ostör AG, Nie G, Lopata A, Salamonsen LA. Cancer; 2002 Mar 01; 94(5):1466-75. PubMed ID: 11920503 [Abstract] [Full Text] [Related]
53. Differential expression and origin of membrane-type 1 and 2 matrix metalloproteinases (MT-MMPs) in association with MMP2 activation in injured human livers. Théret N, Musso O, L'Helgoualc'h A, Campion JP, Clément B. Am J Pathol; 1998 Sep 01; 153(3):945-54. PubMed ID: 9736043 [Abstract] [Full Text] [Related]
54. Modulation of neutral protease expression in human mesangial cells by hyperglycaemic culture. Abdel Wahab N, Mason RM. Biochem J; 1996 Dec 15; 320 ( Pt 3)(Pt 3):777-83. PubMed ID: 9003362 [Abstract] [Full Text] [Related]
55. Analysis of MT1-MMP and MMP2 expression in human gastric cancers. Mori M, Mimori K, Shiraishi T, Fujie T, Baba K, Kusumoto H, Haraguchi M, Ueo H, Akiyoshi T. Int J Cancer; 1997 Jun 20; 74(3):316-21. PubMed ID: 9221811 [Abstract] [Full Text] [Related]
56. Effect of epidermal growth factor and transforming growth factor beta 1 on growth and invasive potentials of newly established rat bladder carcinoma cell lines. Kawamata H, Kameyama S, Nan L, Kawai K, Oyasu R. Int J Cancer; 1993 Dec 02; 55(6):968-73. PubMed ID: 8253534 [Abstract] [Full Text] [Related]
57. Loss of the metastatic phenotype by a human epidermoid carcinoma cell line, HEp-3, is accompanied by increased expression of tissue inhibitor of metalloproteinase 2. Testa JE. Cancer Res; 1992 Oct 15; 52(20):5597-603. PubMed ID: 1327511 [Abstract] [Full Text] [Related]
58. Variable expression of cathepsin B and D correlates with highly invasive and metastatic phenotype of oral cancer. Vigneswaran N, Zhao W, Dassanayake A, Muller S, Miller DM, Zacharias W. Hum Pathol; 2000 Aug 15; 31(8):931-7. PubMed ID: 10987253 [Abstract] [Full Text] [Related]
59. [The effects of MMPs and TIMPs on the metastasis of oral squamous cell carcinoma to neck lymph nodes]. Liu G, Li J, Li Z, Chen X. Hua Xi Kou Qiang Yi Xue Za Zhi; 2001 Aug 15; 19(4):216-8, 224. PubMed ID: 12539723 [Abstract] [Full Text] [Related]
60. Matrix metalloproteinases 2 and 9 in oral squamous cell carcinomas: manifestation and localization of their activity. Kato K, Hara A, Kuno T, Kitaori N, Huilan Z, Mori H, Toida M, Shibata T. J Cancer Res Clin Oncol; 2005 Jun 15; 131(6):340-6. PubMed ID: 15614523 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]